- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Bile acid-mediated signaling in cholestatic liver diseases ; volume:13 ; number:1 ; day:29 ; month:4 ; year:2023 ; pages:1-15 ; date:12.2023
Cell & bioscience ; 13, Heft 1 (29.4.2023), 1-15, 12.2023
- Urheber
-
Zeng, Jing
Fan, Jiangao
Zhou, Huiping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13578-023-01035-1
- URN
-
urn:nbn:de:101:1-2023090510430992534116
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zeng, Jing
- Fan, Jiangao
- Zhou, Huiping
- SpringerLink (Online service)
Ähnliche Objekte (12)
The gut microbiota-bile acid axis in cholestatic liver disease
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
Highlight report : Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury
Emodin alleviates cholestatic liver injury by modulating Sirt1/Fxr signaling pathways
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases
Bile Acid Signaling in Inflammatory Bowel Diseases
Colitis alleviates cholestatic liver injury and fibrosis by inhibiting bile acid synthesis in Mdr2-/- mice
Role of bile acids in inflammatory liver diseases
PHB2 interacts with LC3 and SQSTM1 is required for bile acids-induced mitophagy in cholestatic liver
The gut microbiota-bile acid axis in cholestatic liver disease
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
Highlight report : Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury
Emodin alleviates cholestatic liver injury by modulating Sirt1/Fxr signaling pathways
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases
Bile Acid Signaling in Inflammatory Bowel Diseases
Colitis alleviates cholestatic liver injury and fibrosis by inhibiting bile acid synthesis in Mdr2-/- mice
Role of bile acids in inflammatory liver diseases
PHB2 interacts with LC3 and SQSTM1 is required for bile acids-induced mitophagy in cholestatic liver
The gut microbiota-bile acid axis in cholestatic liver disease
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
Highlight report : Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
Activation of Nrf2/HO-1 signaling pathway exacerbates cholestatic liver injury
Emodin alleviates cholestatic liver injury by modulating Sirt1/Fxr signaling pathways
The role of liver regeneration-associated protein ALR, Augmenter of Liver Regeneration, in cholestatic liver diseases
Bile Acid Signaling in Inflammatory Bowel Diseases
Colitis alleviates cholestatic liver injury and fibrosis by inhibiting bile acid synthesis in Mdr2-/- mice
Role of bile acids in inflammatory liver diseases